The "Transcatheter Embolization and Occlusion Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global transcatheter embolization and occlusion devices market to grow with a CAGR of 9.5% over the period of 2017-2023.

The report on transcatheter embolization and occlusion devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global transcatheter embolization and occlusion devices market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global transcatheter embolization and occlusion devices market over the period of 2015-2023. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Segments Covered

Product

  • Liquid Embolics
  • Embolization Particles
  • Flow Diverter Devices
  • Embolization Coils
  • Accessories

Application

  • Urology
  • Oncology
  • Neurology
  • Peripheral Vascular Disease

End-User

  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers

Companies Profiled

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker
  • Cook Medical
  • Sirtex Medical Limited
  • Johnson & Johnson
  • Medtronic plc
  • DePuy Synthes
  • Penumbra Inc.
  • Nordian

For more information about this report visit https://www.researchandmarkets.com/research/d7ppxp/global?w=4